New Blood Test May Predict Alzheimer's Years Before Symptoms Appear: Study Shows
Advertisement
Researchers have identified a blood marker that reflects the amount of Alzheimer's pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer's drugs.
Key points from the study:
The blood-based marker (P-tau217) may start to change several years before the onset of Alzheimer's symptoms. The marker can be measured using a simpler and cheaper analytical method.
Compared with a highly specialised analytical method, the fully automated method demonstrated a high level of accuracy.
The accuracy was over 90 percent regardless of age, gender, co-morbidity or whether the test is done in a specialist or primary care setting.
A multicentre study has now evaluated a simpler method of analysis for alzheimer’s disease. In total, 1,767 people with cognitive symptoms were included in the study.
The researchers used two cut-offs as the main method to determine whether the blood sample should be interpreted as positive or negative. If a test result is above the upper cut-off, it is classified as positive, i.e. the presence of Alzheimer's disease pathology. If it is below the lower cut-off, it is classified as negative. Values between these cut-offs fall into a grey area and are not assessed in the analysis.
The results were slightly less reliable (83-87%) for the oldest group included in the study if only one cut-off was used.
The simpler method of analysis means that a blood test for Alzheimer's disease can be introduced even in small hospitals.
"When the method was tested in patient groups, the accuracy was between 92 and 94 per cent," says Noëlle Warmenhoven, researcher and doctoral student in clinical memory research at Lund University, and first co-author. "This is very promising as this method is likely to become one of the more widely used methods in clinical practice worldwide, including Sweden."
Reference: https://www.lunduniversity.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.